http://www.onemedplace.com/blog/wp-content/uploads/2009/05/pillsmoney.jpg
Pharmaceutical company MediciNova announced that it will buy Avigen (AVGN) for $1.24 per share, approximately $37 million.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/04/pills.jpg
It was good news for Novartis and bad news for Merck KGaA this week as regulators handed down their decisions on each company’s multiple sclerosis (MS) drug candidate.
View Article
More Pages to Explore .....
